Sharp Corp shares yesterday jumped the most in 22 months in Tokyo trading after the electronics maker controlled by Foxconn Technology Group (富士康科技集團), known as Hon Hai Precision Industry Co (鴻海精密) in Taiwan, canceled plans to raise as much as ¥200 billion (US$1.8 billion) in a public share sale.
The Japanese company, which had planned to use the proceeds to purchase preferred stock and improve its finances, cited market instability fueled by US-China trade tensions.
Sharp also retracted a full-year report related to the sale, it said in a statement.
The shares rose 15 percent to ¥2,700 at the close, the biggest advance since August 2016.
“The threat of dilution was one of the main reasons for the recent share price declines,” Ace Research Institute analyst Hideki Yasuda said. “With that out of the way, it’s easier for investors to buy back in.”
Foxconn took control of the company in 2016 and injected money for capital investments.
The shares rose to a peak of about ¥5,000 last year before sliding over concerns of weaker demand for smartphones and displays that Sharp makes for companies, including Apple Inc.
“Due to US-China trade friction, the stock market has become more volatile, so to continue with the new share issue would not be beneficial to our shareholders and stakeholders,” Sharp said in the statement.
Sharp had planned to spend ¥185 billion to buy back 200,000 preferred shares and retire the share class.
The remainder of the proceeds were to be used on capital expenditure, as well as research and development.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained